Skip to content
The Nexus
BUSINESSAug 4 · 11:44 UTCWTOP DCWTOP Staff

ImmunityBio: Q2 Earnings Snapshot

ImmunityBio, Inc. reported a second-quarter loss of $230.4 million, or 22 cents per share, with adjusted losses of 8 cents per share. The company generated $51.2 million in revenue during the period.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
ImmunityBio, Inc.organizationSan DiegoplaceAutomated InsightsorganizationZacks Investment ResearchorganizationIBRXorganizationimmunotherapytopic
Spot something wrong with this article?Report a problem →
Forward this